Safety and efficacy of stereotactic body radiation therapy combined with S-1 simultaneously followed by sequential S-1 as an initial treatment for locally advanced pancreatic cancer (SILAPANC) trial: study design and rationale of a phase II clinical trial. [electronic resource]
Producer: 20171201Description: e013220 p. digitalISSN:- 2044-6055
- Antimetabolites, Antineoplastic -- administration & dosage
- Chemoradiotherapy -- methods
- Disease-Free Survival
- Drug Combinations
- Humans
- Oxonic Acid -- administration & dosage
- Pancreatic Neoplasms -- pathology
- Quality of Life
- Radiosurgery -- adverse effects
- Research Design
- Survival Rate
- Tegafur -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.